These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 3893084)
1. Therapeutic inequivalence of pharmaceutical alternates. Levy RA Am Pharm; 1985 Apr; NS25(4):28-39. PubMed ID: 3893084 [No Abstract] [Full Text] [Related]
2. [The consequence of the preparation factors for the effect of the drug]. Johnsgård M; Pedersen AO Tidsskr Nor Laegeforen; 1973 Apr; 93(10):698-703. PubMed ID: 4755086 [No Abstract] [Full Text] [Related]
3. Bioavailability and bioequivalence of topical glucocorticoids. Wiedersberg S; Leopold CS; Guy RH Eur J Pharm Biopharm; 2008 Mar; 68(3):453-66. PubMed ID: 17826047 [TBL] [Abstract][Full Text] [Related]
4. Drug formulation and biologic availability. Poole JW Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883 [No Abstract] [Full Text] [Related]
7. The pharmaceutical and biological availability of commercial preparations of furosemide. Stüber W; Mutschler E; Steinbach D Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429 [TBL] [Abstract][Full Text] [Related]
8. Influence of formulation factors on the availability of drugs from topical preparations. Asche H; Botta L; Rettig H; Weirich EG Pharm Acta Helv; 1985; 60(8):232-7. PubMed ID: 4070318 [No Abstract] [Full Text] [Related]
9. [Absorption of the drug-contents of enteric-coated tablets]. Tikkanen R Nord Med; 1967 Nov; 78(47):1564-7. PubMed ID: 6075282 [No Abstract] [Full Text] [Related]
11. [Tablets in stool? A common problem!]. Schuerch LV; Nyfeler J; Holder G; Surber C; Haefeli WE Schweiz Med Wochenschr; 1999 May; 129(17):670-3. PubMed ID: 10407938 [TBL] [Abstract][Full Text] [Related]
12. Striving for standards in bioequivalence assessment: a review. Schulz HU; Steinijans VW Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S1-6. PubMed ID: 1601528 [No Abstract] [Full Text] [Related]
13. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs]. Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793 [TBL] [Abstract][Full Text] [Related]
15. [Effect of formulation of enterosoluable preparations on the physiologic availability of the active principle. 1: Effect on the rate of liberation of acetylsalicylic acid from enteric tablets on absorption characteristics in vivo]. Delporte JP; Jaminet F J Pharm Belg; 1975; 30(2):99-113. PubMed ID: 1206458 [No Abstract] [Full Text] [Related]